Unknown

Dataset Information

0

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

ABSTRACT:

SUBMITTER: Zheng KI 

PROVIDER: S-EPMC7166301 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

Zheng Kenneth I KI   Gao Feng F   Wang Xiao-Bo XB   Sun Qing-Feng QF   Pan Ke-Hua KH   Wang Ting-Yao TY   Ma Hong-Lei HL   Chen Yong-Ping YP   Liu Wen-Yue WY   George Jacob J   Zheng Ming-Hua MH  

Metabolism: clinical and experimental 20200419

Similar Datasets

Unknown Metabolic-associated fatty liver disease is associated with severity of COVID-19.
| S-EPMC7361853 | biostudies-literature
Unknown Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study".
| S-EPMC11540366 | biostudies-literature
Unknown Letter to the Editor
| S-EPMC2253249 | biostudies-literature
Unknown Letter from the Editor
| S-EPMC2791307 | biostudies-literature
Unknown LETTER TO THE EDITOR.
| S-EPMC8428242 | biostudies-literature
Unknown Letter to the Editor.
| S-EPMC11622550 | biostudies-literature
Unknown Letter to the editor.
| S-EPMC2643412 | biostudies-literature
Unknown Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis.
| S-EPMC7498251 | biostudies-literature
Unknown Letter to the Editor: Is Omeprazole a contributing risk factor for osteoarthritis (OA)?
| S-EPMC11468222 | biostudies-literature
Unknown Letter from the Editor in Chief.
| S-EPMC8712058 | biostudies-literature